Hematology
News
FDA approves first gene therapy for hemophilia B
The gene therapy will cost $3.5 million, making it the most expensive treatment to date.
Feature
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
Conference Coverage
I am not fine: The heavy toll cancer takes
“I thought I was as exhausted, and isolated, and neglected as I could get, and then he came home.”
Feature
Worldwide trial seeks to revolutionize pediatric leukemia care
Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.
From the Journals
Children born from frozen embryos may have increased cancer risk
The results, however, “should be interpreted cautiously,” the authors noted, given the low number of cancer cases reported among children born...
Latest News
Children with sickle cell anemia not getting treatments, screening
Annual screenings are recommended as is treatment with hydroxyurea, but only about half of affected children are getting lifesaving care.
Latest News
AAP guidance helps distinguish bleeding disorders from abuse
Laboratory testing of bleeding cannot always rule out abuse, just as a history of trauma may not rule out a bleeding disorder or other medical...
Latest News
Newborns get routine heel blood tests, but should states keep those samples?
Some states allow the blood spots to be used in research studies, sometimes by third parties for a fee, or provided to law enforcement personnel...
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.